Promising Advancements in Gene Therapy: Buy Recommendation for Rocket Pharmaceuticals
William Blair analyst Sami Corwin has maintained their bullish stance on RCKT stock, giving a Buy rating on November 15.Don't Miss our Black ...
Promising Phase 1 Trial Data and Market Potential Propel Buy Rating for Rocket ...
Jason Zemansky, an analyst from Bank of America Securities, reiterated the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The ...
Azorobotics on MSN5 天
Machine Learning Improves Aerosol Prediction Accuracy
The integration of machine learning into the GEOS-Chem model enhances aerosol simulations, providing critical insights for ...
Elastic (ESTC) Q2 2025 Earnings Call Transcript
Operator Good day, and welcome to the Elastic second quarter fiscal 2025 earnings results conference call. All participants will be in listen-only mode. [Operator instructions] After today's ...